BC
WST icon

Bayforest Capital’s West Pharmaceutical WST Stock Holding History

Bayforest Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$317K Buy
883
+706
+399% +$216K 0.29% 56
2026
Q1 		$44.4K Sell
177
-123
-41% -$30.6K 0.05% 589
2025
Q4 		$82.5K Sell
300
-1,499
-83% -$410K 0.06% 511
2025
Q3 		$472K Buy
1,799
+1,274
+243% +$310K 0.22% 160
2025
Q2 		$115K Buy
525
+258
+97% +$55.2K 0.05% 454
2025
Q1 		$59.8K Sell
267
-39
-13% -$10.7K 0.03% 543
2024
Q4 		$100K Buy
+306
New +$96.3K 0.13% 310

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Bayforest Capital's WST Position: Q2 2026 in Review

Bayforest Capital increased its West Pharmaceutical (WST) stake by 399% in Q2 2026, buying an estimated $216K and bringing the position to 883 shares worth $317K. The position accounts for 0.29% of the portfolio, ranked #56.

Bayforest Capital first reported a position in WST in Q4 2024 and has held it in 7 quarters since. The position peaked at $472K in Q3 2025. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Bayforest Capital held 883 shares of West Pharmaceutical worth $317K as of Q2 2026.
  • Bayforest Capital bought 706 West Pharmaceutical shares in Q2 2026, an estimated $216K.
  • West Pharmaceutical made up 0.29% of Bayforest Capital's portfolio in Q2 2026, its #56 holding.
  • Bayforest Capital first reported a position in West Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • Bayforest Capital's West Pharmaceutical position peaked at $472K in Q3 2025.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.